Overview
Chandra Belani is a Hematologist Oncology specialist and an Oncologist in Hershey, Pennsylvania. Dr. Belani is rated as an Experienced provider by MediFind in the treatment of Ovarian Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.
His clinical research consists of co-authoring 111 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 3 clinical trials in the study of Ovarian Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
18 Clinical Trials
UPMC Gynecologic Oncology
Joshua Kesterson, MD, is a fellowship-trained gynecologic oncologist and medical director of the gynecologic oncology program at UPMC in Central Pa. He received his medical degree from the University of Missouri and completed his residency in obstetrics, gynecology and women’s health at the University of Louisville, followed by his fellowship in gynecologic oncology at Roswell Park Cancer Institute. He is board-certified in obstetrics and gynecology and gynecologic oncology by the American Board of Obstetrics and Gynecology. Dr. Kesterson’s clinical interests include gynecologic oncology such as ovarian, cervical, and endometrial cancer, immunotherapy, and HPV, and his research interests include quality improvement, ovarian cancer, and endometrial carcinoma. He is a member of the Society for Gynecologic Oncologists, the Foundation for Women’s Cancer, and Alpha Omega Alpha Honor Society. Dr. Kesterson is rated as a Distinguished provider by MediFind in the treatment of Ovarian Cancer. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor.
Greater Baltimore Medical Center Inc
Paul Celano is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Celano is rated as a Distinguished provider by MediFind in the treatment of Ovarian Cancer. His top areas of expertise are Ovarian Cancer, Testicular Yolk Sac Tumor, Virilizing Ovarian Tumor, and Ovarian Carcinosarcoma.
UPMC Gynecologic Oncology
Gregory Willis, DO, specializes in gynecologic oncology and is certified by the American Osteopathic Board of Obstetrics and Gynecology. He practices at PinnacleHealth Women's Cancer Center and is affiliated with UPMC Lititz, UPMC Memorial, UPMC Hanover, UPMC Harrisburg, UPMC Community Osteopathic, and UPMC West Shore. He completed his fellowship at Community General Osteopathic Hospital, medical school at University of North Texas, residency at Erlanger Health System, and residency at Community Hospital of Lancaster. Dr. Willis is rated as a Distinguished provider by MediFind in the treatment of Ovarian Cancer. His top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Desmoplastic Small Round Cell Tumor, Ovarian Cancer, and Hernia Surgery.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Belani isElite. Learn about Lung Cancer.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Belani isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Belani isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Belani isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Belani isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Belani isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerDr. Belani isAdvanced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaDr. Belani isAdvanced. Learn about Febrile Neutropenia.
- Large-Cell Lung CarcinomaDr. Belani isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Belani isAdvanced. Learn about Lung Adenocarcinoma.
- Triple-Negative Breast CancerDr. Belani isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- AgranulocytosisDr. Belani isExperienced. Learn about Agranulocytosis.
- Breast CancerDr. Belani isExperienced. Learn about Breast Cancer.
- Lung NodulesDr. Belani isExperienced. Learn about Lung Nodules.
- MesotheliomaDr. Belani isExperienced. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Belani isExperienced. Learn about Metastatic Pleural Tumor.
- Neuroendocrine TumorDr. Belani isExperienced. Learn about Neuroendocrine Tumor.

